메뉴 건너뛰기




Volumn 34, Issue 6, 2012, Pages 1422-1431

Pharmacokinetic Profile of Beclomethasone Dipropionate Hydrofluoroalkane After Intranasal Administration Versus Oral Inhalation in Healthy Subjects: Results of a Single-Dose, Randomized, Open-Label, 3-Period Crossover Study

Author keywords

[No Author keywords available]

Indexed keywords

BECLOMETASONE DIPROPIONATE; BECLOMETHASONE 17 MONOPROPIONATE; DRUG METABOLITE; FLUORINATED HYDROCARBON; UNCLASSIFIED DRUG;

EID: 84862116335     PISSN: 01492918     EISSN: 1879114X     Source Type: Journal    
DOI: 10.1016/j.clinthera.2012.04.023     Document Type: Article
Times cited : (16)

References (18)
  • 2
    • 47749085883 scopus 로고    scopus 로고
    • The diagnosis and management of rhinitis: an updated practice parameter
    • Wallace D.V., Dykewicz M.S., Bernstein D.I., et al. The diagnosis and management of rhinitis: an updated practice parameter. J Allergy Clin Immunol 2008, 122(Suppl 2):S1-S84.
    • (2008) J Allergy Clin Immunol , vol.122 , Issue.SUPPL. 2
    • Wallace, D.V.1    Dykewicz, M.S.2    Bernstein, D.I.3
  • 3
    • 0034912161 scopus 로고    scopus 로고
    • Allergic rhinitis: definition, epidemiology, pathophysiology, detection, and diagnosis
    • Skoner D.P. Allergic rhinitis: definition, epidemiology, pathophysiology, detection, and diagnosis. J Allergy Clin Immunol 2001, 108(Suppl 1):S2-S8.
    • (2001) J Allergy Clin Immunol , vol.108 , Issue.SUPPL. 1
    • Skoner, D.P.1
  • 4
    • 0002885825 scopus 로고    scopus 로고
    • Allergic rhinitis and its impact on asthma
    • ARIA Workshop Group
    • Bousquet J. Allergic rhinitis and its impact on asthma. J Allergy Clin Immunol 2001, 108:S147-S334. ARIA Workshop Group.
    • (2001) J Allergy Clin Immunol , vol.108
    • Bousquet, J.1
  • 5
    • 0032512287 scopus 로고    scopus 로고
    • Intranasal corticosteroids versus oral H1 receptor antagonists in allergic rhinitis: systematic review of randomised controlled trials
    • Weiner J.M., Abramson M.J., Puy R.M. Intranasal corticosteroids versus oral H1 receptor antagonists in allergic rhinitis: systematic review of randomised controlled trials. BMJ 1998, 317:1624-1629.
    • (1998) BMJ , vol.317 , pp. 1624-1629
    • Weiner, J.M.1    Abramson, M.J.2    Puy, R.M.3
  • 6
    • 79953179336 scopus 로고    scopus 로고
    • Is there a role for aerosol nasal sprays in the treatment of allergic rhinitis
    • Luskin A.T., Blaiss M.S., Farrar J.R., et al. Is there a role for aerosol nasal sprays in the treatment of allergic rhinitis. Allergy Asthma Proc 2011, 32:168-177.
    • (2011) Allergy Asthma Proc , vol.32 , pp. 168-177
    • Luskin, A.T.1    Blaiss, M.S.2    Farrar, J.R.3
  • 7
    • 84859637120 scopus 로고    scopus 로고
    • Insights on allergic rhinitis from the patient perspective
    • Fromer L.M., Ortiz G., Ryan S.F., Stoloff S.W. Insights on allergic rhinitis from the patient perspective. J Fam Pract 2012, 61(Suppl 2):S16-S22.
    • (2012) J Fam Pract , vol.61 , Issue.SUPPL. 2
    • Fromer, L.M.1    Ortiz, G.2    Ryan, S.F.3    Stoloff, S.W.4
  • 8
    • 34447251521 scopus 로고    scopus 로고
    • Patient and physician perspectives on the attributes of nasal allergy medications
    • Naclerio R.M., Hadley J.A., Stoloff S., Nelson H.S. Patient and physician perspectives on the attributes of nasal allergy medications. Allergy Asthma Proc 2007, 28:S11-S17.
    • (2007) Allergy Asthma Proc , vol.28
    • Naclerio, R.M.1    Hadley, J.A.2    Stoloff, S.3    Nelson, H.S.4
  • 10
    • 84872611438 scopus 로고    scopus 로고
    • Accessed September 28, 2011
    • Montreal Protocol Accessed September 28, 2011. http://www.epa.gov/ozone/intpol/.
    • Montreal Protocol
  • 12
    • 84862119417 scopus 로고    scopus 로고
    • Safety and efficacy of once-daily treatment with beclomethasone dipropionate nasal aerosol in subjects with perennial allergic rhinitis
    • Meltzer E.O., Jacobs R.L., LaForce C.F., Kelley L., Dunbar S.A., Tantry S.K. Safety and efficacy of once-daily treatment with beclomethasone dipropionate nasal aerosol in subjects with perennial allergic rhinitis. Allergy Asthma Proc 2012, 33:249-257.
    • (2012) Allergy Asthma Proc , vol.33 , pp. 249-257
    • Meltzer, E.O.1    Jacobs, R.L.2    LaForce, C.F.3    Kelley, L.4    Dunbar, S.A.5    Tantry, S.K.6
  • 13
    • 0034854302 scopus 로고    scopus 로고
    • Beclomethasone dipropionate: absolute bioavailability, pharmacokinetics and metabolism following intravenous, oral, intranasal and inhaled administration in man
    • Daley-Yates P.T., Price A.C., Sisson J.R., Pereira A., Dallow N. Beclomethasone dipropionate: absolute bioavailability, pharmacokinetics and metabolism following intravenous, oral, intranasal and inhaled administration in man. Br J Clin Pharmacol 2001, 51:400-409.
    • (2001) Br J Clin Pharmacol , vol.51 , pp. 400-409
    • Daley-Yates, P.T.1    Price, A.C.2    Sisson, J.R.3    Pereira, A.4    Dallow, N.5
  • 14
    • 0031837092 scopus 로고    scopus 로고
    • Beclomethasone relative availability of oral versus inhaled beclomethasone dipropionate from an HFA-134A metered dose inhaler
    • Soria I., Harrison L.I., Machacek J.H., Cline A.C., Stampone P.A. Beclomethasone relative availability of oral versus inhaled beclomethasone dipropionate from an HFA-134A metered dose inhaler. Biopharm Drug Dispos 1998, 19:297-302.
    • (1998) Biopharm Drug Dispos , vol.19 , pp. 297-302
    • Soria, I.1    Harrison, L.I.2    Machacek, J.H.3    Cline, A.C.4    Stampone, P.A.5
  • 15
    • 33748779835 scopus 로고    scopus 로고
    • Effects of inhaled steroids on growth, bone metabolism, and adrenal function
    • Allen D.B. Effects of inhaled steroids on growth, bone metabolism, and adrenal function. Adv Pediatr 2006, 53:101-110.
    • (2006) Adv Pediatr , vol.53 , pp. 101-110
    • Allen, D.B.1
  • 16
    • 23044439607 scopus 로고    scopus 로고
    • How the lung handles drugs: pharmacokinetics and pharmacodynamics of inhaled corticosteroids
    • Winkler J., Hochhaus G., Derendorf H. How the lung handles drugs: pharmacokinetics and pharmacodynamics of inhaled corticosteroids. Proc Am Thorac Soc 2004, 1:356-363.
    • (2004) Proc Am Thorac Soc , vol.1 , pp. 356-363
    • Winkler, J.1    Hochhaus, G.2    Derendorf, H.3
  • 17
    • 0032589989 scopus 로고    scopus 로고
    • Inhaled and nasal corticosteroids: factors affecting the risks of systemic adverse effects
    • Cave A., Arlett P., Lee E. Inhaled and nasal corticosteroids: factors affecting the risks of systemic adverse effects. Pharmacol Ther 1999, 83:153-179.
    • (1999) Pharmacol Ther , vol.83 , pp. 153-179
    • Cave, A.1    Arlett, P.2    Lee, E.3
  • 18
    • 74549183716 scopus 로고    scopus 로고
    • Pharmacokinetics of ciclesonide and desisobutyryl ciclesonide after administration via aqueous nasal spray or hydrofluoroalkane nasal aerosol compared with orally inhaled ciclesonide: an open-label, single-dose, three-period crossover study in healthy volunteers
    • Nave R., Herzog R., Laurent A., Wingertzahn M.A. Pharmacokinetics of ciclesonide and desisobutyryl ciclesonide after administration via aqueous nasal spray or hydrofluoroalkane nasal aerosol compared with orally inhaled ciclesonide: an open-label, single-dose, three-period crossover study in healthy volunteers. Clin Ther 2009, 31:2988-2999.
    • (2009) Clin Ther , vol.31 , pp. 2988-2999
    • Nave, R.1    Herzog, R.2    Laurent, A.3    Wingertzahn, M.A.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.